Academic Bibliography

 Search 200 years of publications by Ghent University researchers.
Advanced search
2 files | 3.61 MB
Add to list
  1. Search results
  2. Attributable mortality of ventilator-...

Attributable mortality of ventilator-associated pneumonia : replicating findings, revisiting methods

Johan Steen (UGent) , Stijn Vansteelandt (UGent) , Liesbet De Bus (UGent) , Pieter Depuydt (UGent) , Bram Gadeyne (UGent) , Dominique Benoit (UGent) and Johan Decruyenaere (UGent)
(2021) ANNALS OF THE AMERICAN THORACIC SOCIETY. 18(5). p.830-837
Author
Organization
Abstract
Rationale: Estimating the impact of ventilator-associated pneumonia (VAP) from routinely collected ICU data is methodologically challenging. Objectives: We aim to replicate earlier findings of limited VAP-attributable ICU mortality in an independent cohort. By refining statistical analyses, we gradually tackle different sources of bias. Methods: Records of 2,720 adult patients admitted to Ghent University Hospital ICUs (2013—2017) and receiving mechanical ventilation within 48 hours following admission were extracted from linked ICIS and COSARA databases. The VAP-attributable fraction of ICU mortality was estimated using a competing risk analysis that is restricted to VAP-free patients (approach 1), accounts for VAP onset by treating it as either a competing (approach 2) or censoring event (approach 3), or additionally adjusts for time-dependent confounding via inverse probability weighting (approach 4). Results: Two hundred ten patients (7.7%) acquired VAP. Based on benchmark approach 4, we estimated that (compared to current preventive measures) hypothetical eradication of VAP would lead to a relative ICU mortality reduction of 1.7% (95% confidence interval: -1.3—4.6) by day 10 and of 3.6% (95% confidence interval: 0.7—6.5) by day 60. Approaches 1—3 produced estimates ranging from -0.7 to 2.5% by day 10, and from 5.2 to 5.5% at day 60. Conclusions: In line with previous studies using appropriate methodology, we found limited VAP-attributable ICU mortality given current state-of-the-art VAP prevention measures. Our study illustrates that inappropriate accounting of the time-dependency of exposure and confounding of its effects may misleadingly suggest protective effects of early-onset VAP and systematically overestimate attributable mortality.
Keywords
hospital mortality, survival analysis, confounding factors (epidemiology), causality, ventilator-associated pneumonia, BONE-MARROW-TRANSPLANTATION, CARE-ASSOCIATED INFECTIONS, MULTISTATE MODELS, SURVEILLANCE, IMPACT, LENGTH, STAY, UNIT

Downloads

  • Download
    published version.pdf
    • full text (Published version)
    • |
    • open access
    • |
    • PDF
    • |
    • 670.72 KB
  • Download
    Supplementary Material Steen et al. - 2021 - Annals of the American Thoracic Society 2 .pdf
    • supplementary material
    • |
    • open access
    • |
    • PDF
    • |
    • 2.93 MB

Citation

Please use this url to cite or link to this publication:

MLA
Steen, Johan, et al. “Attributable Mortality of Ventilator-Associated Pneumonia : Replicating Findings, Revisiting Methods.” ANNALS OF THE AMERICAN THORACIC SOCIETY, vol. 18, no. 5, 2021, pp. 830–37, doi:10.1513/AnnalsATS.202004-385OC.
APA
Steen, J., Vansteelandt, S., De Bus, L., Depuydt, P., Gadeyne, B., Benoit, D., & Decruyenaere, J. (2021). Attributable mortality of ventilator-associated pneumonia : replicating findings, revisiting methods. ANNALS OF THE AMERICAN THORACIC SOCIETY, 18(5), 830–837. https://doi.org/10.1513/AnnalsATS.202004-385OC
Chicago author-date
Steen, Johan, Stijn Vansteelandt, Liesbet De Bus, Pieter Depuydt, Bram Gadeyne, Dominique Benoit, and Johan Decruyenaere. 2021. “Attributable Mortality of Ventilator-Associated Pneumonia : Replicating Findings, Revisiting Methods.” ANNALS OF THE AMERICAN THORACIC SOCIETY 18 (5): 830–37. https://doi.org/10.1513/AnnalsATS.202004-385OC.
Chicago author-date (all authors)
Steen, Johan, Stijn Vansteelandt, Liesbet De Bus, Pieter Depuydt, Bram Gadeyne, Dominique Benoit, and Johan Decruyenaere. 2021. “Attributable Mortality of Ventilator-Associated Pneumonia : Replicating Findings, Revisiting Methods.” ANNALS OF THE AMERICAN THORACIC SOCIETY 18 (5): 830–837. doi:10.1513/AnnalsATS.202004-385OC.
Vancouver
1.
Steen J, Vansteelandt S, De Bus L, Depuydt P, Gadeyne B, Benoit D, et al. Attributable mortality of ventilator-associated pneumonia : replicating findings, revisiting methods. ANNALS OF THE AMERICAN THORACIC SOCIETY. 2021;18(5):830–7.
IEEE
[1]
J. Steen et al., “Attributable mortality of ventilator-associated pneumonia : replicating findings, revisiting methods,” ANNALS OF THE AMERICAN THORACIC SOCIETY, vol. 18, no. 5, pp. 830–837, 2021.
@article{8688725,
  abstract     = {{Rationale: Estimating the impact of ventilator-associated pneumonia (VAP) from routinely collected ICU data is methodologically challenging.
Objectives: We aim to replicate earlier findings of limited VAP-attributable ICU mortality in an independent cohort. By refining statistical analyses, we gradually tackle different sources of bias.
Methods: Records of 2,720 adult patients admitted to Ghent University Hospital ICUs (2013—2017) and receiving mechanical ventilation within 48 hours following admission were extracted from linked ICIS and COSARA databases. The VAP-attributable fraction of ICU mortality was estimated using a competing risk analysis that is restricted to VAP-free patients (approach 1), accounts for VAP onset by treating it as either a competing (approach 2) or censoring event (approach 3), or additionally adjusts for time-dependent confounding via inverse probability weighting (approach 4).
Results: Two hundred ten patients (7.7%) acquired VAP. Based on benchmark approach 4, we estimated that (compared to current preventive measures) hypothetical eradication of VAP would lead to a relative ICU mortality reduction of 1.7% (95% confidence interval: -1.3—4.6) by day 10 and of 3.6% (95% confidence interval: 0.7—6.5) by day 60. Approaches 1—3 produced estimates ranging from -0.7 to 2.5% by day 10, and from 5.2 to 5.5% at day 60.
Conclusions: In line with previous studies using appropriate methodology, we found limited VAP-attributable ICU mortality given current state-of-the-art VAP prevention measures. Our study illustrates that inappropriate accounting of the time-dependency of exposure and confounding of its effects may misleadingly suggest protective effects of early-onset VAP and systematically overestimate attributable mortality.}},
  author       = {{Steen, Johan and Vansteelandt, Stijn and De Bus, Liesbet and Depuydt, Pieter and Gadeyne, Bram and Benoit, Dominique and Decruyenaere, Johan}},
  issn         = {{1546-3222}},
  journal      = {{ANNALS OF THE AMERICAN THORACIC SOCIETY}},
  keywords     = {{hospital mortality,survival analysis,confounding factors (epidemiology),causality,ventilator-associated pneumonia,BONE-MARROW-TRANSPLANTATION,CARE-ASSOCIATED INFECTIONS,MULTISTATE MODELS,SURVEILLANCE,IMPACT,LENGTH,STAY,UNIT}},
  language     = {{eng}},
  number       = {{5}},
  pages        = {{830--837}},
  title        = {{Attributable mortality of ventilator-associated pneumonia : replicating findings, revisiting methods}},
  url          = {{http://doi.org/10.1513/AnnalsATS.202004-385OC}},
  volume       = {{18}},
  year         = {{2021}},
}
Altmetric
View in Altmetric
Web of Science
Times cited: